Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Stacy J. Kegel"'
Autor:
Farideh Mehraein-Ghomi, George Wilding, Dawn R. Church, Stacy J. Kegel, Hirak S. Basu, Joseph S. Schmidt, Quentin R. Reuter, Elizabeth L. Saphner
Publikováno v:
The Prostate. 74:792-803
BACKGROUND Multiple studies show that reactive oxygen species (ROS) play a major role in prostate cancer (PCa) development and progression. Previously, we reported an induction of Spermidine/Spermine N1-Acetyl Transferase (SSAT) by androgen-activated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2637ebb6132e990b7ee2d976953e554e
https://doi.org/10.1002/pros.22800
https://doi.org/10.1002/pros.22800
Autor:
Stacy J. Kegel, Amy Mahlum, Farideh Mehraein-Ghomi, Song Guo, George Wilding, Hirak S. Basu, Noël R. Peters
Publikováno v:
Cancer Chemotherapy and Pharmacology. 67:705-715
Most prostate, colon and breast cancer cells are resistant to growth inhibitory effects of suberoylanilide hydroxamic acid (SAHA). We have examined whether the high oxidative stress in these cells causes a loss of SAHA activity and if so, whether pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e6de0c717529503419589e095d7b6ac
https://doi.org/10.1007/s00280-010-1364-3
https://doi.org/10.1007/s00280-010-1364-3
Autor:
Farideh Mehraein-Ghomi, Quentin R. Reuter, George Wilding, Joseph S. Schmidt, Hirak S. Basu, Stacy J. Kegel, Dawn R. Church, F. Michael Hoffmann, Elizabeth L. Saphner
Publikováno v:
Cancer Research. 72:2844-2844
Development of an effective therapy to prevent prostate cancer (PCa) progression to castrate-resistant PCa (CRPCa) remains an unmet medical need, mainly due to a poor understanding of the mechanism of PCa progression. Reactive oxygen species (ROS) ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b101a7da83bb989fa53ded0e98994c9
https://doi.org/10.1158/1538-7445.am2012-2844
https://doi.org/10.1158/1538-7445.am2012-2844
Autor:
Dawn R. Church, F. Michael Hoffmann, Hirak S. Basu, Quentin R. Reuter, Stacy J. Kegel, Farideh Mehraein-Ghomi, Joseph S. Schmidt, George Wilding
Publikováno v:
Cancer Research. 71:2583-2583
Development of an effective therapy to prevent prostate cancer (PCa) progression to castrate-resistant PCa (CRPCa) remains an unmet medical need, mainly due to a poor understanding of the mechanism of PCa progression. Reactive oxygen species (ROS) ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7adf3c4fd627aa62973ce1d45b172383
https://doi.org/10.1158/1538-7445.am2011-2583
https://doi.org/10.1158/1538-7445.am2011-2583